Greenfield Seitz Capital Management’s Thermo Fisher Scientific TMO Stock Holding History

Greenfield Seitz Capital Management’s Portfolio TMO Stock Details TMO Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q1	–	Sell	-350	Closed	-$203K	–	115
2025 Q4	$203K	Buy	+350	New	+$198K	0.07%	104
2025 Q1	–	Sell	-500	Closed	-$260K	–	113
2024 Q4	$260K	Buy	+500	New	+$275K	0.1%	92
2024 Q1	–	Sell	-500	Closed	-$265K	–	109
2023 Q4	$265K	Buy	+500	New	+$242K	0.11%	92

Other funds holding TMO

BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM

State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return

Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return

Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return

Franklin Resources San Mateo, California $462B AUM 39.16% 1-Year Est. Return

Capital World Investors Los Angeles, California $846B AUM 46.74% 1-Year Est. Return

JP Morgan Chase New York $1.81T AUM 41.13% 1-Year Est. Return

T. Rowe Price Associates Baltimore, Maryland $999B AUM 46.22% 1-Year Est. Return

Greenfield Seitz Capital Management's TMO Position: Q1 2026 in Review

Greenfield Seitz Capital Management sold out of Thermo Fisher Scientific (TMO) in Q1 2026, closing a stake of 350 shares — an estimated $203K sold.

Greenfield Seitz Capital Management first reported a position in TMO in Q4 2023 and held it in 3 quarters. The position peaked at $265K in Q4 2023. 2,600 funds tracked by Wall St. Rank hold TMO as of Q1 2026.

Greenfield Seitz Capital Management reported no remaining Thermo Fisher Scientific position as of Q1 2026 after selling out during the quarter.
Greenfield Seitz Capital Management sold 350 Thermo Fisher Scientific shares in Q1 2026, an estimated $203K.
Greenfield Seitz Capital Management first reported a position in Thermo Fisher Scientific in Q4 2023 and held it in 3 quarters.
Greenfield Seitz Capital Management's Thermo Fisher Scientific position peaked at $265K in Q4 2023.
2,600 funds tracked by Wall St. Rank held Thermo Fisher Scientific as of Q1 2026.

Based on Greenfield Seitz Capital Management's 13F filing for Q1 2026, filed 24 Apr 2026.